{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T12:31:10Z","timestamp":1794745870711,"version":"4.9.1"},"reference-count":26,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2026,8,31]]},"DOI":"10.5582\/bst.2026.01000","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:09:22Z","timestamp":1779314962000},"page":"412-424","source":"Crossref","is-referenced-by-count":2,"title":["PRXL2B facilitates the progression of hepatocellular carcinoma and the therapeutic efficacy of oncolytic adenovirus H101 through the PI3K\/AKT\/PD-L1 axis"],"prefix":"10.5582","volume":"20","author":[{"given":"Ziqi","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Chen","sequence":"first","affiliation":[{"name":"Nanchuan District Maternal and Child Health Care Hospital, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangming","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Obstetric, The Affiliated Banan Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."},{"name":"Department of Pathology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxi","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuotian","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjun","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqing","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Chongqing Jiulongpo People&apos;s Hospital, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Che","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Shapingba Hospital affiliated to Chongqing University (Shapingba District People&apos;s Hospital of Chongqing), Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2020; 1873:188314.","DOI":"10.1016\/j.bbcan.2019.188314"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Raja J, Ludwig JM, Gettinger SN, Schalper KA, Kim HS. Oncolytic virus immunotherapy: future prospects for oncology. J Immunother Cancer. 2018; 6:140.","DOI":"10.1186\/s40425-018-0458-z"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Abudoureyimu M, Lai Y, Tian C, Wang T, Wang R, Chu X. Corrigendum: Oncolytic Adenovirus-A Nova for Gene-Targeted Oncolytic Viral Therapy in HCC. Front Oncol. 2020; 10:701.","DOI":"10.3389\/fonc.2020.00701"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Mantwill K, Klein FG, Wang D, Hindupur SV, Ehrenfeld M, Holm PS, Nawroth R. Concepts in Oncolytic Adenovirus Therapy. Int J Mol Sci. 2021; 22:10522.","DOI":"10.3390\/ijms221910522"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Duan Y, Bai H, Li X, Wang D, Wang Y, Cao M, Zhang N, Chen H, Wang Y. Oncolytic Adenovirus H101 Synergizes with Radiation in Cervical Cancer Cells. Curr Cancer Drug Targets. 2021; 21:619-630.","DOI":"10.2174\/1568009621666210308103541"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Qiao C, Xu Y, He Y, Cai Z, Wang H. Oncolytic adenovirus H101 enhances the anti-tumor effects of PD-1 blockade <i>via<\/i> CD47 downregulation in tumor cells. Oncol Res. 2025; 33:1161-1172.","DOI":"10.32604\/or.2024.055746"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Xi P, Zeng D, Chen M, Jiang L, Zhang Y, Qin D, Yao Z, He C. Enhancing pancreatic cancer treatment: The role of H101 oncolytic virus in irreversible electroporation. Front Immunol. 2025; 16:1546242.","DOI":"10.3389\/fimmu.2025.1546242"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Santos Apolonio J, Lima de Souza Gon\u00e7alves V, Cordeiro Santos ML, Silva Luz M, Silva Souza JV, Rocha Pinheiro SL, de Souza WR, Sande Loureiro M, de Melo FF. Oncolytic virus therapy in cancer: A current review. World J Virol. 2021; 10:229-255.","DOI":"10.5501\/wjv.v10.i5.229"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kaufman HL, Kohlhapp FJ, Zloza A. Oncolytic viruses: a new class of immunotherapy drugs. Nat Rev Drug Discov. 2015; 14:642-662.","DOI":"10.1038\/nrd4663"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. van Lieshout L, van de Stolpe A, van der Ploeg P, Bowtell D, de Hullu J, Piek J. Signal Transduction Pathway Activity in High-Grade, Serous Ovarian Carcinoma Reveals a More Favorable Prognosis in Tumors with Low PI3K and High NF-\u03baB Pathway Activity: A Novel Approach to a Long-Standing Enigma. Cancers (Basel). 2020; 12:2660.","DOI":"10.3390\/cancers12092660"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Song D, Jia X, Liu X, <i>et al<\/i>. Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumors. Signal Transduct Target Ther. 2022; 7:100.","DOI":"10.1038\/s41392-022-00921-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Shi ZR, Duan YX, Cui F, Wu ZJ, Li MP, Song PP, Peng QL, Ye WT, Yin KL, Kang MQ, Yu YX, Yang J, Tang W, Liao R. Integrated proteogenomic characterization reveals an imbalanced hepatocellular carcinoma microenvironment after incomplete radiofrequency ablation. J Exp Clin Cancer Res. 2023; 42:133.","DOI":"10.1186\/s13046-023-02716-y"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Cheng AL, Hsu C, Chan SL, Choo SP, Kudo M. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma. J Hepatol. 2020; 72:307-319.","DOI":"10.1016\/j.jhep.2019.09.025"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Budhu A, Roessler S, Zhao X, Yu Z, Forgues M, Ji J, Karoly E, Qin LX, Ye QH, Jia HL, Fan J, Sun HC, Tang ZY, Wang XW. Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology. 2013; 144:1066-1075.e1061.","DOI":"10.1053\/j.gastro.2013.01.054"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Amicone L, Citarella F, Cicchini C. Epigenetic regulation in hepatocellular carcinoma requires long noncoding RNAs. Biomed Res Int. 2015; 2015:473942.","DOI":"10.1155\/2015\/473942"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Gao Q, Zhu H, Dong L, <i>et al<\/i>. Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. Cell. 2019; 179:561-577.e522.","DOI":"10.1016\/j.cell.2019.08.052"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Song W, Yuan Y, Cao F, Pan H, Liu Y. The key pathways and genes related to oncolytic Newcastle disease virus-induced phenotypic changes in ovarian cancer cells. J Microbiol. 2025; 63:e2411018.","DOI":"10.71150\/jm.2411018"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Marchini A, Ilkow CS, Melcher A. Oncolytic Virus Immunotherapy. Cancers (Basel). 2021; 13:3672.","DOI":"10.3390\/cancers13153672"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ghasemi Darestani N, Gilmanova AI, Al-Gazally ME, Zekiy AO, Ansari MJ, Zabibah RS, Jawad MA, Al-Shalah SAJ, Rizaev JA, Alnassar YS, Mohammed NM, Mustafa YF, Darvishi M, Akhavan-Sigari R. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment. Cell Commun Signal. 2023; 21:43.","DOI":"10.1186\/s12964-022-01012-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kaufman HL, Maciorowski D. Advancing oncolytic virus therapy by understanding the biology. Nat Rev Clin Oncol. 2021; 18:197-198.","DOI":"10.1038\/s41571-021-00490-4"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wang Z, Sun P, Li Z, Xiao S. Clinical Advances and Future Directions of Oncolytic Virotherapy for Head and Neck Cancer. Cancers (Basel). 2023; 15:5291.","DOI":"10.3390\/cancers15215291"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kui X, Wang Y, Zhang C, Li H, Li Q, Ke Y, Wang L. Prognostic value of SH3PXD2B (Tks4) in human hepatocellular carcinoma: a combined multi-omics and experimental study. BMC Med Genomics. 2021; 14:115.","DOI":"10.1186\/s12920-021-00963-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021; 6:425.","DOI":"10.1038\/s41392-021-00828-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nishida N, Sakai K, Morita M, Aoki T, Takita M, Hagiwara S, Komeda Y, Takenaka M, Minami Y, Ida H, Ueshima K, Nishio K, Kudo M. Association between Genetic and Immunological Background of Hepatocellular Carcinoma and Expression of Programmed Cell Death-1. Liver Cancer. 2020; 9:426-439.","DOI":"10.1159\/000506352"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Samson A, Bentham MJ, Scott K, <i>et al<\/i>. Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer. Gut. 2018; 67:562-573.","DOI":"10.1136\/gutjnl-2016-312009"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hin Tang JJ, Hao Thng DK, Lim JJ, Toh TB. JAK\/STAT signaling in hepatocellular carcinoma. Hepat Oncol. 2020; 7:HEP18.","DOI":"10.2217\/hep-2020-0001"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/20\/4\/20_2026.01000\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:29:14Z","timestamp":1789792154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/20\/4\/20_2026.01000\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2026.01000","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"article-number":"2026.01000"}}